Amgen’s trial drug to fight autoimmune disorder improves patient outcomes
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Amgen Inc.’s experimental drug to treat patients suffering from a rare muscle-weakening disease, myasthenia gravis, has shown positive results in an end-stage trial.
IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain.
September 24, 2024: Teva Pharmaceuticals presented new research demonstrating effective strategies for switching adult patients with schizophrenia from Perseris to Uzedy (risperidone extended-release.
The US national public agency has issued a Health Alert Network on the ongoing outbreak of the Clade I monkeypox virus, warning its.
About one in seven adolescents in the age group of 10-19 suffer from mental disorders such as depression and anxiety, according to the.
"There is a fine line between genius and insanity" is often used to describe individuals who exhibit exceptional talent in various fields. Movies.
British-Swedish AstraZeneca and Japan's Daiichi Sankyo’s investigational drug for breast cancer failed to significantly improve the overall survival of the patients during an.
Researchers at the University of Cambridge have developed a wearable ‘smart choker’ to help people communicate after speech impairments resulting from surgery or.
The West Asian Hashemite Kingdom of Jordan has been designated as the first country in the world to be verified by the WHO.
Denmark’s Novo Nordisk got the backing of the European Medicines Agency for its Wegovy drug to reduce heart failure in obese people.